Search results: Sage Journals

Open accessCase reportFirst published May, 2023

A case of toxic epidermal necrolysis associated with lenvatinib and sintilimab therapy for intrahepatic cholangiocarcinoma

Yinhua Gong, Jinzhu Mao, Ming Liu [...]

Journal of International Medical Research

Restricted accessResearch articleFirst published March, 2026

Anlotinib Plus Sintilimab for BRAF V600E Negative Unresectable or Metastatic Anaplastic Thyroid Carcinoma: A Single-Center,Single-Arm,Phase 2 Trial

Lin Gui, Haohua Zhu, Le Tang [...]

Thyroid®

Open accessResearch articleFirst published April, 2022

Rapid subcutaneous progression after immunotherapy in pretreated patients with metastatic carcinoma: two case reports

Yong Da, Ge Shen, Ming Zhou [...]

Journal of International Medical Research

Open accessResearch articleFirst published 2025

Sintilimab + Nab-PP Combined with Recombinant Human Vascular Endothelial Inhibitor for Locally Advanced/Advanced and Recurrent Metastatic Squamous Non-Small Cell Lung Cancer: Study Protocol for a Single-Arm,Multi-Centre Phase II Clinical Study

Junzhu Xu, Mi Meng, Sisi He [...]

Technology in Cancer Research & Treatment

Open accessResearch articleFirst published 2022

A Retrospective Study on Therapeutic Efficacy of Transarterial Chemoembolization Combined With Immune Checkpoint Inhibitors Plus Lenvatinib in Patients With Unresectable Hepatocellular Carcinoma

Ying Teng, Xiaoyan Ding, Wendong Li [...]

Technology in Cancer Research & Treatment

Open accessReview articleFirst published 2024

Immune checkpoint inhibitors versus chemotherapy as second-line therapy for advanced oesophageal squamous cell carcinoma: a systematic review and economic evaluation

Shixian Liu, Lei Dou, Shunping Li

Therapeutic Advances in Gastroenterology

Open accessCase reportFirst published June, 2023

Treatment of a case of primary alveolar soft part sarcoma of the lung: Case report and literature review

Feiyang Li, Haowei Lu, Dong Zhao [...]

Journal of International Medical Research

Open accessCase reportFirst published April, 2021

Primary central nervous system Hodgkin's lymphoma: a case report

Haiying Fu, Songsheng Shi, Lusan Chen [...]

Journal of International Medical Research

Open accessResearch articleFirst published 2025

Cost-effectiveness analysis of Cadonilimab in first-line treatment of advanced HER2-negative gastric cancer or gastroesophageal junction cancer

Kaiqi Zhu, Mengyao Qin, Zhaoyi Pan [...]

Therapeutic Advances in Gastroenterology

Open accessResearch articleFirst published 2024

Immune checkpoint inhibitors or anti-claudin 18.2 antibodies? A network meta-analysis for the optimized first-line therapy of HER2-negative gastric cancer

Zhening Zhang, Tong Xie, Yingxuan Wang [...]

Therapeutic Advances in Medical Oncology

Open accessCase reportFirst published May, 2023

A case of toxic epidermal necrolysis associated with lenvatinib and sintilimab therapy for intrahepatic cholangiocarcinoma

Yinhua Gong, Jinzhu Mao, Ming Liu [...]

Journal of International Medical Research

Restricted accessResearch articleFirst published March, 2026

Anlotinib Plus Sintilimab for BRAF V600E Negative Unresectable or Metastatic Anaplastic Thyroid Carcinoma: A Single-Center,Single-Arm,Phase 2 Trial

Lin Gui, Haohua Zhu, Le Tang [...]

Thyroid®

Open accessResearch articleFirst published April, 2022

Rapid subcutaneous progression after immunotherapy in pretreated patients with metastatic carcinoma: two case reports

Yong Da, Ge Shen, Ming Zhou [...]

Journal of International Medical Research

Open accessResearch articleFirst published 2025

Sintilimab + Nab-PP Combined with Recombinant Human Vascular Endothelial Inhibitor for Locally Advanced/Advanced and Recurrent Metastatic Squamous Non-Small Cell Lung Cancer: Study Protocol for a Single-Arm,Multi-Centre Phase II Clinical Study

Junzhu Xu, Mi Meng, Sisi He [...]

Technology in Cancer Research & Treatment

Open accessResearch articleFirst published 2022

A Retrospective Study on Therapeutic Efficacy of Transarterial Chemoembolization Combined With Immune Checkpoint Inhibitors Plus Lenvatinib in Patients With Unresectable Hepatocellular Carcinoma

Ying Teng, Xiaoyan Ding, Wendong Li [...]

Technology in Cancer Research & Treatment

Open accessReview articleFirst published 2024

Immune checkpoint inhibitors versus chemotherapy as second-line therapy for advanced oesophageal squamous cell carcinoma: a systematic review and economic evaluation

Shixian Liu, Lei Dou, Shunping Li

Therapeutic Advances in Gastroenterology

Open accessCase reportFirst published June, 2023

Treatment of a case of primary alveolar soft part sarcoma of the lung: Case report and literature review

Feiyang Li, Haowei Lu, Dong Zhao [...]

Journal of International Medical Research

Open accessCase reportFirst published April, 2021

Primary central nervous system Hodgkin's lymphoma: a case report

Haiying Fu, Songsheng Shi, Lusan Chen [...]

Journal of International Medical Research

Open accessResearch articleFirst published 2025

Cost-effectiveness analysis of Cadonilimab in first-line treatment of advanced HER2-negative gastric cancer or gastroesophageal junction cancer

Kaiqi Zhu, Mengyao Qin, Zhaoyi Pan [...]

Therapeutic Advances in Gastroenterology

Open accessResearch articleFirst published 2024

Immune checkpoint inhibitors or anti-claudin 18.2 antibodies? A network meta-analysis for the optimized first-line therapy of HER2-negative gastric cancer

Zhening Zhang, Tong Xie, Yingxuan Wang [...]

Therapeutic Advances in Medical Oncology